Mediso Medical Imaging Systems   Laborc. u. 3. H-1037 Budapest Hungary Telephone: +36-1-3993030 Telefax: +36-1-3993040 Email: info@mediso.com

 

Preclinical Products

nanoScan - the four modality in vivo molecular imaging platform

Members of the nanoScan® Family combine the industry’s highest performing microscopy level of NM imaging supported by excellent MRI and CT performance.

The ultimate versatility and in-line combinations of the systems are based on common software, common animal handling platform and easy on-site upgrade possibility, thus fulfil all demands of your growing and long term research requirements.

 

With the nanoScan® Family Mediso designed a platform that can satisfy the increasing needs of any research institute with shared components and flexible upgrade possibilities. Exclusive features only from Mediso nanoScan® Family:


- Two MRI and two CT based bimodal solutions
- Highest visible resolution in NM modalities: 275 µm SPECT and 700 µm PET
- Highest PET and SPECT quantification accuracy: over 97% in both modalities
- Dynamic list mode acquisition for both PET and SPECT
- Fulfil low to high budget requirements with continuous on-site upgrade path
- Worldwide exclusive factory support through equipment lifetime (guaranteed for more than 10 years for all systems including NanoSPECT/CT and NanoPET/CT)

 

nanoScan SPECT/CT/PET

nanoScan SPECT/CT

nanoScan PET/CT

nanoScan SPECT/MRI

nanoScan PET/MRI



Download nanoScan Family brochure

 

Continuous upgrade path for the users:


For imaging facilities already using the world market leader NanoSPECT/CT® system (manufactured by Mediso) the nanoScan® Family with the newest and most advanced technology are unique opportunities to upgrade onto the next level of multi-modality imaging.

 

© 2016 Mediso Ltd. All rights reserved.   * Contacts & Partners   * Terms of use   * Privacy Policy   * C.S. & Trademarks